Integrated Data Management for Multicentric Imaging in Investigator-Initiated Trials (IITs)
Establishing a Framework for Multicentric Data Coordination
For many investigators, the transition from a single-site study to a multicentric model…
Categories: Multi-site Clinical Trials
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
Potential of longitudinal data from single site and multi-center clinical trials for AI-research
Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this…
MROC: The Impact of mpMRI on the Staging and Management of Patients with Suspected or Confirmed OC
Funded by the National Institute of Health Research (NIHR) and sponsored by the Imperial College London, the MROC study boasts impressive figures: 645…